Skip to main content
. 2022 May 11;13:684–685. doi: 10.18632/oncotarget.27523

Figure 2. Knockdown of CASC9 inhibited proliferation and invasion.

(A) Expression level of CASC9 in BGC823/DR and SGC7901/DR cells after transfection of pS-CASC9. (B) Growth curve of BGC823/DR cells after CASC9 knockdown. (C) Growth curve of SGC7901/DR cells after CASC9 knockdown. (D) Apoptosis of BGC823/DR and SGC7901/DR cells after CASC9 knockdown. (E) Invasion assay by transwell analysis of BGC823/DR and SGC7901/DR cells after CASC9 knockdown. (F) CASC9 knockdown decreased the numbers of trans-membrance BGC823/DR and SGC7901/DR cells.

Figure 2